1 – 10 of 24
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2007
-
Mark
Antagonism of the prostaglandin D2 receptor CRTH2 attenuates asthma pathology in mouse eosinophilic airway inflammation.
(
- Contribution to journal › Article
-
Mark
Neurokinin-1 receptor antagonism in a rat model of subarachnoid hemorrhage: prevention of upregulation of contractile ETB and 5-HT1B receptors and cerebral blood flow reduction
(
- Contribution to journal › Article
-
Mark
Nature's choice of genes controlling chronic inflammation.
2007) Symposium on Immunotherapy 2020 - Visions and Trends for Targeting Inflammatory Disease 4. p.1-15(
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
- 2006
-
Mark
Om möss och människor. Inte givet att fynd hos alzheimermöss kan appliceras i klinisk verklighet
(
- Contribution to journal › Article
- 2005
-
Mark
Impairment and recovery of postural control in rabbits with spinal cord lesions.
(
- Contribution to journal › Article
-
Mark
The use of the R6 transgenic mouse models of Huntington's disease in attempts to develop novel therapeutic strategies.
(
- Contribution to journal › Article
- 2004
-
Mark
Topical, single dose bisphosphonate treatment reduced bone resorption in a rat model for prosthetic loosening.
(
- Contribution to journal › Article
- 2003
-
Mark
BMP treatment for improving tendon repair. Studies on rat and rabbit Achilles tendons.
(
- Contribution to journal › Scientific review
-
Mark
Cellular and behavioural effects of the adenosine A2a receptor antagonist KW-6002 in a rat model of l-DOPA-induced dyskinesia.
(
- Contribution to journal › Article
- 2002
-
Mark
Maintenance of susceptibility to neurodegeneration following intrastriatal injections of quinolinic acid in a new transgenic mouse model of Huntington's disease.
(
- Contribution to journal › Article